Back
Hansa Biopharma AB Stock Price Chart
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
29
HNSBF
Hansa Biopharma AB
Last Price:
$2.91
Seasonality Move:
-3.88%
7 Day Trial
ALL ACCESS PASS
$
7
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
The current trend is relatively stagnant and HNSBF is experiencing slight buying pressure.
Hansa Biopharma AB Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.91 | Sell |
| 20-day SMA: | 2.91 | Sell |
| 50-day SMA: | 3.78 | Sell |
| 200-day SMA: | 3.15 | Sell |
| 8-day EMA: | 2.92 | Sell |
| 20-day EMA: | 3.1 | Sell |
| 50-day EMA: | 3.37 | Sell |
| 200-day EMA: | 3.25 | Sell |
Hansa Biopharma AB Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.24 | Sell |
| Relative Strength Index (14 RSI): | 12.68 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.57 - 3.79) | Sell |
| Bollinger Bands (100): | (2.52 - 4.06) | Sell |
Hansa Biopharma AB Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Hansa Biopharma AB Stock
Is Hansa Biopharma AB Stock a Buy?
-
Hansa Biopharma AB share price is 2.91 while HNSBF 8-day simple moving average is 2.91, which is a Sell signal.
-
The stock price of HNSBF is 2.91 while Hansa Biopharma AB 20-day SMA is 2.91, which makes it a Sell.
-
Hansa Biopharma AB 50-day simple moving average is 3.78 while HNSBF share price is 2.91, making it a Sell technically.
-
HNSBF stock price is 2.91 and Hansa Biopharma AB 200-day simple moving average is 3.15, creating a Sell signal.
HNSBF Technical Analysis vs Fundamental Analysis
Sell
29
Hansa Biopharma AB (HNSBF)
is a Sell
Is Hansa Biopharma AB a Buy or a Sell?
-
Hansa Biopharma AB stock is rated a SellThe current Hansa Biopharma AB [HNSBF] share price is $2.91. The Score for HNSBF is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
Hansa Biopharma AB Stock Info
Market Cap:
290.2M
Price in USD:
2.91
Share Volume:
0
Hansa Biopharma AB 52-Week Range
52-Week High:
4.58
52-Week Low:
2.73
Sell
29
Hansa Biopharma AB (HNSBF)
is a Sell
Hansa Biopharma AB Share Price Forecast
-
What is the Hansa Biopharma AB stock price today?The Hansa Biopharma AB stock price is 2.91 USD today.
-
Will HNSBF stock go up or go down?Hansa Biopharma AB> share price is forecast to RISE/FALL based on technical indicators
-
Is Hansa Biopharma AB overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Hansa Biopharma AB is overvalued.
Is Hansa Biopharma AB Stock a Buy?
-
Hansa Biopharma AB share price is 2.91 while HNSBF 8-day exponential moving average is 2.92, which is a Sell signal.
-
The stock price of HNSBF is 2.91 while Hansa Biopharma AB 20-day EMA is 3.10, which makes it a Sell.
-
Hansa Biopharma AB 50-day exponential moving average is 3.37 while HNSBF share price is 2.91, making it a Sell technically.
-
HNSBF stock price is 2.91 and Hansa Biopharma AB 200-day simple moving average is 3.25, creating a Sell signal.
Technical Analysis of Hansa Biopharma AB
Should I short Hansa Biopharma AB stock?
-
HNSBF Moving Average Covergence Divergence (MACD) indicator is -0.24, suggesting Hansa Biopharma AB is a Sell
-
Hansa Biopharma AB Relative Strength Index (RSI) is 12.68, which suggest Hansa Biopharma AB is oversold
-
The Bollinger Bands (25) for Hansa Biopharma AB is (2.57 - 3.79), which suggest Hansa Biopharma AB is a Sell
-
The Bollinger Bands (100) for Hansa Biopharma AB is (2.52 - 4.06), which suggest Hansa Biopharma AB is a Sell
* Hansa Biopharma AB stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.